Debulking surgery for colorectal liver metastases: Foolish or chance?
Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, p...
Ausführliche Beschreibung
Autor*in: |
Adam, René [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2020 |
---|
Schlagwörter: |
---|
Umfang: |
4 |
---|
Übergeordnetes Werk: |
Enthalten in: Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma - Zheng, Rongjiong ELSEVIER, 2018, a review journal of cancer management and research, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:33 ; year:2020 ; pages:266-269 ; extent:4 |
Links: |
---|
DOI / URN: |
10.1016/j.suronc.2020.02.008 |
---|
Katalog-ID: |
ELV050672258 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV050672258 | ||
003 | DE-627 | ||
005 | 20230624165556.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200625s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.suronc.2020.02.008 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001103.pica |
035 | |a (DE-627)ELV050672258 | ||
035 | |a (ELSEVIER)S0960-7404(20)30042-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 570 |q VZ |
084 | |a BIODIV |q DE-30 |2 fid | ||
084 | |a 35.70 |2 bkl | ||
084 | |a 42.12 |2 bkl | ||
100 | 1 | |a Adam, René |e verfasserin |4 aut | |
245 | 1 | 0 | |a Debulking surgery for colorectal liver metastases: Foolish or chance? |
264 | 1 | |c 2020 | |
300 | |a 4 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations. | ||
650 | 7 | |a Chemotherapy |2 Elsevier | |
650 | 7 | |a Debulking surgery |2 Elsevier | |
650 | 7 | |a Cytoreduction |2 Elsevier | |
650 | 7 | |a Colorectal liver metastases |2 Elsevier | |
700 | 1 | |a Kitano, Yuki |4 oth | |
700 | 1 | |a Abdelrafee, Ahmed |4 oth | |
700 | 1 | |a Allard, Marc-Antoine |4 oth | |
700 | 1 | |a Baba, Hideo |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Zheng, Rongjiong ELSEVIER |t Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma |d 2018 |d a review journal of cancer management and research |g Amsterdam [u.a.] |w (DE-627)ELV001144405 |
773 | 1 | 8 | |g volume:33 |g year:2020 |g pages:266-269 |g extent:4 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.suronc.2020.02.008 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-BIODIV | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 35.70 |j Biochemie: Allgemeines |q VZ |
936 | b | k | |a 42.12 |j Biophysik |q VZ |
951 | |a AR | ||
952 | |d 33 |j 2020 |h 266-269 |g 4 |
author_variant |
r a ra |
---|---|
matchkey_str |
adamrenkitanoyukiabdelrafeeahmedallardma:2020----:euknsreyoclrcalvreats |
hierarchy_sort_str |
2020 |
bklnumber |
35.70 42.12 |
publishDate |
2020 |
allfields |
10.1016/j.suronc.2020.02.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001103.pica (DE-627)ELV050672258 (ELSEVIER)S0960-7404(20)30042-6 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Adam, René verfasserin aut Debulking surgery for colorectal liver metastases: Foolish or chance? 2020 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations. Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases Elsevier Kitano, Yuki oth Abdelrafee, Ahmed oth Allard, Marc-Antoine oth Baba, Hideo oth Enthalten in Elsevier Science Zheng, Rongjiong ELSEVIER Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma 2018 a review journal of cancer management and research Amsterdam [u.a.] (DE-627)ELV001144405 volume:33 year:2020 pages:266-269 extent:4 https://doi.org/10.1016/j.suronc.2020.02.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 33 2020 266-269 4 |
spelling |
10.1016/j.suronc.2020.02.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001103.pica (DE-627)ELV050672258 (ELSEVIER)S0960-7404(20)30042-6 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Adam, René verfasserin aut Debulking surgery for colorectal liver metastases: Foolish or chance? 2020 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations. Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases Elsevier Kitano, Yuki oth Abdelrafee, Ahmed oth Allard, Marc-Antoine oth Baba, Hideo oth Enthalten in Elsevier Science Zheng, Rongjiong ELSEVIER Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma 2018 a review journal of cancer management and research Amsterdam [u.a.] (DE-627)ELV001144405 volume:33 year:2020 pages:266-269 extent:4 https://doi.org/10.1016/j.suronc.2020.02.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 33 2020 266-269 4 |
allfields_unstemmed |
10.1016/j.suronc.2020.02.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001103.pica (DE-627)ELV050672258 (ELSEVIER)S0960-7404(20)30042-6 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Adam, René verfasserin aut Debulking surgery for colorectal liver metastases: Foolish or chance? 2020 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations. Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases Elsevier Kitano, Yuki oth Abdelrafee, Ahmed oth Allard, Marc-Antoine oth Baba, Hideo oth Enthalten in Elsevier Science Zheng, Rongjiong ELSEVIER Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma 2018 a review journal of cancer management and research Amsterdam [u.a.] (DE-627)ELV001144405 volume:33 year:2020 pages:266-269 extent:4 https://doi.org/10.1016/j.suronc.2020.02.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 33 2020 266-269 4 |
allfieldsGer |
10.1016/j.suronc.2020.02.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001103.pica (DE-627)ELV050672258 (ELSEVIER)S0960-7404(20)30042-6 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Adam, René verfasserin aut Debulking surgery for colorectal liver metastases: Foolish or chance? 2020 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations. Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases Elsevier Kitano, Yuki oth Abdelrafee, Ahmed oth Allard, Marc-Antoine oth Baba, Hideo oth Enthalten in Elsevier Science Zheng, Rongjiong ELSEVIER Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma 2018 a review journal of cancer management and research Amsterdam [u.a.] (DE-627)ELV001144405 volume:33 year:2020 pages:266-269 extent:4 https://doi.org/10.1016/j.suronc.2020.02.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 33 2020 266-269 4 |
allfieldsSound |
10.1016/j.suronc.2020.02.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001103.pica (DE-627)ELV050672258 (ELSEVIER)S0960-7404(20)30042-6 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Adam, René verfasserin aut Debulking surgery for colorectal liver metastases: Foolish or chance? 2020 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations. Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases Elsevier Kitano, Yuki oth Abdelrafee, Ahmed oth Allard, Marc-Antoine oth Baba, Hideo oth Enthalten in Elsevier Science Zheng, Rongjiong ELSEVIER Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma 2018 a review journal of cancer management and research Amsterdam [u.a.] (DE-627)ELV001144405 volume:33 year:2020 pages:266-269 extent:4 https://doi.org/10.1016/j.suronc.2020.02.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 33 2020 266-269 4 |
language |
English |
source |
Enthalten in Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma Amsterdam [u.a.] volume:33 year:2020 pages:266-269 extent:4 |
sourceStr |
Enthalten in Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma Amsterdam [u.a.] volume:33 year:2020 pages:266-269 extent:4 |
format_phy_str_mv |
Article |
bklname |
Biochemie: Allgemeines Biophysik |
institution |
findex.gbv.de |
topic_facet |
Chemotherapy Debulking surgery Cytoreduction Colorectal liver metastases |
dewey-raw |
570 |
isfreeaccess_bool |
false |
container_title |
Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma |
authorswithroles_txt_mv |
Adam, René @@aut@@ Kitano, Yuki @@oth@@ Abdelrafee, Ahmed @@oth@@ Allard, Marc-Antoine @@oth@@ Baba, Hideo @@oth@@ |
publishDateDaySort_date |
2020-01-01T00:00:00Z |
hierarchy_top_id |
ELV001144405 |
dewey-sort |
3570 |
id |
ELV050672258 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV050672258</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624165556.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200625s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.suronc.2020.02.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001103.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV050672258</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0960-7404(20)30042-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Adam, René</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Debulking surgery for colorectal liver metastases: Foolish or chance?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Debulking surgery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cytoreduction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Colorectal liver metastases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kitano, Yuki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abdelrafee, Ahmed</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Allard, Marc-Antoine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baba, Hideo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Zheng, Rongjiong ELSEVIER</subfield><subfield code="t">Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma</subfield><subfield code="d">2018</subfield><subfield code="d">a review journal of cancer management and research</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001144405</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:33</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:266-269</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.suronc.2020.02.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">33</subfield><subfield code="j">2020</subfield><subfield code="h">266-269</subfield><subfield code="g">4</subfield></datafield></record></collection>
|
author |
Adam, René |
spellingShingle |
Adam, René ddc 570 fid BIODIV bkl 35.70 bkl 42.12 Elsevier Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases Debulking surgery for colorectal liver metastases: Foolish or chance? |
authorStr |
Adam, René |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001144405 |
format |
electronic Article |
dewey-ones |
570 - Life sciences; biology |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Debulking surgery for colorectal liver metastases: Foolish or chance? Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases Elsevier |
topic |
ddc 570 fid BIODIV bkl 35.70 bkl 42.12 Elsevier Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases |
topic_unstemmed |
ddc 570 fid BIODIV bkl 35.70 bkl 42.12 Elsevier Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases |
topic_browse |
ddc 570 fid BIODIV bkl 35.70 bkl 42.12 Elsevier Chemotherapy Elsevier Debulking surgery Elsevier Cytoreduction Elsevier Colorectal liver metastases |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
y k yk a a aa m a a maa h b hb |
hierarchy_parent_title |
Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma |
hierarchy_parent_id |
ELV001144405 |
dewey-tens |
570 - Life sciences; biology |
hierarchy_top_title |
Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV001144405 |
title |
Debulking surgery for colorectal liver metastases: Foolish or chance? |
ctrlnum |
(DE-627)ELV050672258 (ELSEVIER)S0960-7404(20)30042-6 |
title_full |
Debulking surgery for colorectal liver metastases: Foolish or chance? |
author_sort |
Adam, René |
journal |
Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma |
journalStr |
Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science |
recordtype |
marc |
publishDateSort |
2020 |
contenttype_str_mv |
zzz |
container_start_page |
266 |
author_browse |
Adam, René |
container_volume |
33 |
physical |
4 |
class |
570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Adam, René |
doi_str_mv |
10.1016/j.suronc.2020.02.008 |
dewey-full |
570 |
title_sort |
debulking surgery for colorectal liver metastases: foolish or chance? |
title_auth |
Debulking surgery for colorectal liver metastases: Foolish or chance? |
abstract |
Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations. |
abstractGer |
Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations. |
abstract_unstemmed |
Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
title_short |
Debulking surgery for colorectal liver metastases: Foolish or chance? |
url |
https://doi.org/10.1016/j.suronc.2020.02.008 |
remote_bool |
true |
author2 |
Kitano, Yuki Abdelrafee, Ahmed Allard, Marc-Antoine Baba, Hideo |
author2Str |
Kitano, Yuki Abdelrafee, Ahmed Allard, Marc-Antoine Baba, Hideo |
ppnlink |
ELV001144405 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth |
doi_str |
10.1016/j.suronc.2020.02.008 |
up_date |
2024-07-06T18:10:31.236Z |
_version_ |
1803854210648768512 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV050672258</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624165556.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200625s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.suronc.2020.02.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001103.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV050672258</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0960-7404(20)30042-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Adam, René</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Debulking surgery for colorectal liver metastases: Foolish or chance?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Even with the recent advances of surgical techniques and systemic therapies, we are often facing patients with multinodular bilateral disease for whom neither R0 nor R1 resection appears possible to perform. For such extensive cases, the tumor debulking approaches might provide a survival benefit, provided that an objective tumor response is obtained with chemotherapy. Here, we review all the arguments which may defend this strategy and propose some recommendations.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Debulking surgery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cytoreduction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Colorectal liver metastases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kitano, Yuki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abdelrafee, Ahmed</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Allard, Marc-Antoine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baba, Hideo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Zheng, Rongjiong ELSEVIER</subfield><subfield code="t">Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma</subfield><subfield code="d">2018</subfield><subfield code="d">a review journal of cancer management and research</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001144405</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:33</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:266-269</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.suronc.2020.02.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">33</subfield><subfield code="j">2020</subfield><subfield code="h">266-269</subfield><subfield code="g">4</subfield></datafield></record></collection>
|
score |
7.4006147 |